INTEGRIS Pharma S.A

INTEGRIS Pharma is a fast-growing Greek pharmaceutical company. Founded in 2008 as a CNS generics pharma, the company successfully relaunched its business model in 2018, with a clear mission to cover the unmet therapeutic needs of patients with rare, debilitating and life-threatening diseases in Greece and Cyprus, through innovative therapeutics. Consistently serving this new strategic and therapeutic focus, INTEGRIS Pharma is actively seeking for innovative medicines throughout the world and is committed to ensure direct access for all patients, in the countries the company operates. Within the last 5 years, INTEGRIS Pharma has entered into 12 new partnerships with leading, global biopharmaceutical companies and has built an extensive and diverse product portfolio for more than 16 diseases. Its portfolio includes orphan drugs for rare and ultra-rare diseases, innovative biopharmaceuticals complemented with hybrid and generic products in the fields of Oncology and Hematology as we...